Phase I Study of ProAgio in Patients with Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies
Summary
The purpose of this phase I study is to evaluate the safety and efficacy of ProAgio in patients with advanced stage solid tumors, including pancreatic cancer.
General Information
NCT#: NCT05085548
Study ID: 000194
Trial Phase: Phase I
Trial Sponsor: ProDa BioTech, LLC
Therapies Used in This Trial: ProAgio